In the era of immuno-oncology, it’s critical to unravel mechanisms of action underlying sensitivity or resistance to current immunotherapies in order to identify predictive biomarkers of response and then discover novel actionable therapeutic targets.
To deal with the tumor biology complexity/heterogeneity and get compartment’s specific insights (e.g. tumor vs stroma) It’s thus primordial to benefit from a technological platform that allows for spatial profiling.
In this collaborative session organized by NanoString Technologies Inc. in conjunction with Oxford Global: Biomarkers UK, Dr. Alban Bessede will discuss recent findings about new mechanisms underlying response to cancer immunotherapies.
| REGISTER NOW! |